Boehringer Ingelheim PHRMCTCLS

Boehringer Ingelheim Animal Health USA Inc., headquartered in Saint Joseph, MO, is dedicated to the well-being of animals and people through their portfolio of vaccines, parasite control products, and therapeutics. They are committed to delivering value through science and innovation to enhance the health of both animals and humans. With a focus on sustainability and social impact, Boehringer Ingelheim strives to provide a more sustainable future by embracing renewable energy and reducing their carbon footprint. Their team of over 3,000 employees across the United States works tirelessly to prevent disease, champion innovation, and strengthen the bond between people and animals.Generated from the website

The mission of Boehringer Ingelheim Vetmedica is to benefit the health of mankind by contributing to an adequate supply of safe, nutritious food and by promoting the emotional and physical benefits arising from the human-animal bond. The company develops and markets a broad range of products and technologies worldwide for horses, cattle, swine and companion animals. The company has technical service veterinarians and a veteran sales force that bring an extensive line of biological, pharmaceutical and insecticide products to the market. Boehringer seeks input from customers and researchers constantly search for new-generation biologicals, pharmaceuticals and unique compounds to aide food animals, companion animals and horses. Established in 1917, Boehringer Ingelheim Vetmedica has been a subsidiary of Boehringer Ingelheim Corpoartion since 1981 and has headquarters in St. Joseph, Mo.